These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6340563)

  • 1. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of bioavailability and pharmacokinetic profiles between Theodur and a new sustained-release theophylline formulation].
    Morishita M; Nagai T; Ishizaki T; Suganuma T; Kushida K; Minegishi A
    Arerugi; 1986 Nov; 35(11):1099-104. PubMed ID: 3827603
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline bioavailability following oral administration of six sustained-release preparations.
    Spangler DL; Kalof DD; Bloom FL; Wittig HJ
    Ann Allergy; 1978 Jan; 40(1):6-11. PubMed ID: 623398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo testing of a peroral theophylline depot preparation with zero-order release].
    Lippold BC; Förster H
    Arzneimittelforschung; 1984; 34(7):824-9. PubMed ID: 6541919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of two sustained-release theophylline products during once-daily and twice-daily dosing.
    Armstrong EP; Nako N; Plezia PM; Kramer TH; Jones WN
    Clin Pharm; 1987 Oct; 6(10):800-4. PubMed ID: 3505842
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratic absorption of a slow-release theophylline sprinkle product.
    Pedersen S; Møller-Petersen J
    Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 20. [Absorption profile and absolute bioavailability of a theophylline--retard preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1990 Nov; 40(11):1218-24. PubMed ID: 2085333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.